Senator Ron Wyden (D-Ore.), a senior member of the Senate Finance Committee, accused Pfizer (PFE) of carrying out what he ...
The ongoing investigation by Wyden and his Democratic compatriots from the Finance Committee has pointed the finger at ...
Pfizer's $25 support holds strong, with institutional buying signals and growth potential in oncology. Click here to read an ...
Sen. Ron Wyden and other Democrats claim Pfizer used a "colossal" scheme to avoid paying billions in U.S. taxes.
Healthcare stocks have been out of vogue with investors since late 2022. Myriad reasons underlie the negative sentiment ...
We recently published a list of 11 Blue Chip Stocks to Invest in at 52-Week Lows. In this article, we are going to take a ...
BEIJING, March 30 (Xinhua) -- U.S. pharmaceutical giant Pfizer's new research and development (R&D) center officially opened at BioPark in the Beijing Economic-Technological Development Area (BDA) on ...
An exclusive interview with Pfizer’s Wayne Simmons on reshaping customer experience by listening to those interacting with ...